Sirtex Medical Release: Large U.S. Multi-Center Study Confirms Safety and Efficacy of SIR-Spheres® microspheres in More Than 600 Patients with Unresectable Liver Metastases

CHICAGO--(BUSINESS WIRE)--SIR-Spheres® microspheres are well-tolerated and effective internal radiotherapy for unresectable, heavily pre-treated colorectal cancer liver metastases, according to results from a new study of more than 600 patients presented today at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting. The data were presented by lead investigator Andrew Kennedy, M.D., FACRO, from Cancer Centers of North Carolina and North Carolina State University.1 SIR-Spheres microspheres are manufactured by Sirtex and are the only fully FDA-approved microsphere radiation therapy for the treatment of colorectal liver metastases.